We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Immunofluorescence Assay Detects Virulent Escherichia coli

By LabMedica International staff writers
Posted on 15 Oct 2013
A sensitive and specific detection method for identifying enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. More...
coli (EHEC) has been reported.

Among the methods for detection of virulence factor expression, immunoassays for which polyclonal and or monoclonal antibodies are raised, can be considered the first alternative to either animal use or in vitro culture cells assays.

Scientists at Instituto Butantan (Sao Paulo, SP, Brazil) developed a recombinant antibody using the single-chain variable fragment (scFv) approach. They evaluated the sensitivity and specificity of an intimin recombinant antibody (scFv-intimin) using an immunofluorescence assay. A synthetic gene was designed using the scFv-intimin. The intimin adherence-protein gene (eae) encodes for intimin, a 94-kDa outer membrane protein.

The evaluation of scFv-intimin by an indirect immunofluorescence assay test performance implied the use of eae-positive isolates displaying intimin variants, specifically typical EPEC (tEPEC), atypical EPEC (aEPEC), and EHEC, to assess test sensitivity and eae-negative and other Enterobacteriaceae isolates. The prototype tEPEC E2348/69 and enterotoxigenic (ETEC) H10407/E. coli K-12 isolates acted as positive and negative controls, respectively, for assay standardization.

Anti-histidine mouse antibody and goat anti-mouse immunoglobulin G- Fluorescein isothiocyanate (IgG-FITC, Sigma-Aldrich; St. Louis, MO, USA) conjugate were also included as immunofluorescence controls. In all isolates, the eae gene was first assayed by PCR, and the eae positive isolates were confirmed by fluorescent actin staining analysis. A drop of the manipulated bacterial suspension that had also been resuspended with scFv-intimin was placed on a glass slide and observed with a fluorescence microscope (Axioskop-Zeiss; Munich, Germany).

The scFv-intimin immunoassay detected typical EPEC, atypical EPEC, and EHEC isolates with 100% sensitivity and did not detect eae negative isolates, indicating 100% specificity. The authors conclude that immunofluorescence is an effective and rapid method, and scFv-intimin, an excellent tool for the diagnosis of diarrhea caused by EPEC and EHEC and also can be employed in case-control epidemiological surveys. The study was published on October 2, 2013, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Instituto Butantan
Sigma-Aldrich
Axioskop-Zeiss



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit
New
PSA Test
Humasis PSA Card
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.